98%
921
2 minutes
20
Proteins conjugated to cyclic cell-penetrating peptides (cCPPs) haAbstractve been shown to be effectively taken up by living cells. Conjugation of proteins to cCPPs in a cleavable manner leads to localization in the cytosol and immediate bioavailability of the protein after uptake. Here we describe how mCherry, a fluorescent protein, can be targeted to a membrane-bound compartment, the nucleus, and a subcellular structure like the actin cytoskeleton after cCPP-mediated uptake into living cells. Targeting peptides are genetically fused to the mCherry protein sequence and the protein is conjugated to the cCPP via a cleavable disulfide bond. Localization of mCherry in the nucleus or the actin skeleton respectively can be observed by live cell confocal fluorescence microscopy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-1617-8_22 | DOI Listing |
Colloids Surf B Biointerfaces
August 2025
Anhui Engineering Research Center for Neural Regeneration Technology and Medical New Materials, School of Life Sciences, Bengbu Medical University, Bengbu, China; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, Bengbu, China. Ele
Current treatments for bone diseases are facing significant limitations, including adverse side effects, high costs and safety concerns. Surgical interventions and biologics (e.g.
View Article and Find Full Text PDFJ Comput Aided Mol Des
August 2025
Institute of Blood Transfusion and Hematology, Guangzhou First People's Hospital, Guangzhou, 510080, Guangdong, China.
Cyclic peptides, prized for their remarkable bioactivity and stability, hold great promise across various fields. Yet, designing membrane-penetrating bioactive cyclic peptides via traditional methods is complex and resource-intensive. To address this, we introduce CCPep, an AI-driven de novo design framework that combines reinforcement and contrastive learning for efficient, customizable membrane-penetrating cyclic peptide design.
View Article and Find Full Text PDFMol Ther Nucleic Acids
September 2025
Department of Human Genetics, Leiden University Medical Centre, Einthovenweg 20, 2333 ZC Leiden, the Netherlands.
The severe muscle wasting disorder Duchenne muscular dystrophy (DMD) is characterized by the absence of dystrophin, a protein that is essential for muscle stability. Restoring this protein has therapeutic potential. Antisense oligonucleotides (ASOs), designed to target and skip exons, can restore the reading frame that is disrupted in these patients, enabling the production of partially functional dystrophin.
View Article and Find Full Text PDFPharmaceutics
June 2025
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Cell-penetrating peptides cross cell membrane barriers while carrying cargoes in a functional form. Our work identified two novel lung-targeting peptides, S7A and R11A. Here, we present studies on biodistribution, the cell types targeted, and an in vitro proof of application.
View Article and Find Full Text PDFAnal Chem
August 2025
Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX, Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
For the toxicokinetic evaluation of a lipid conjugate of the cell-penetrating peptide cyclic nonaarginine, we aimed to develop a highly sensitive plasma quantification. Due to the amphiphilic properties and high number of basic amino acids, plasma bioanalysis with LC-MS/MS instruments is difficult. Challenges in particular include chromatographic characteristics, minimal extraction recovery, and resistance against collision-induced dissociation.
View Article and Find Full Text PDF